Find a Clinical Trial
Clinical trials offer patients access to emerging treatments that are shaping the future of cancer care. Our clinical research program works alongside your care team to evaluate new therapies, improve how treatments are delivered and enhance quality of life during and after treatment.
If you are interested in participating in a clinical trial, ask your physician if you qualify.Ā To make our clinical trials available to all CARTI patients, all of our physicians serve as sub-investigators; this means that your treating physician can enroll you onto a clinical trial if you are eligible.
Participation in research isĀ always voluntary.Ā For further information on clinical trials, please visitĀ http://www.clinicaltrials.gov.
If you have any additional questions for or about CARTIās Research Team, please call 501.906.4199 or emailĀ Research@CARTI.com.Ā
Principal Investigator: Dr. Sam Makhoul
Study ID Name: D926XC00001, Tropion Breast-03
Sponsor: AstraZeneca
Protocol Title: A Study of Dato-DXd With or Without Durvalumab Versus Investigatorās Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy
Clinicaltrials.gov Number: NCT05629585
Principal Investigator: Dr. Sam Makhoul
Study ID Name: D8534C00001, Serena-6
Sponsor: AstraZeneca
Protocol Title: A Phase III, Double-blind, Randomised Study to Assess Switching to AZD9833 + CDK4/6 Inhibitor vs Continuing AI + CDK4/6 Inhibitor in HR+/HER2- MBC Patients with ctDNA Detectable ESR1 Mutation Without Disease Progression During 1L Treatment
Clinicaltrials.gov Number: NCT04964934
Principal Investigator: Dr. Sam Makhoul
Study ID Name: SGNTUC-028, HER2Climb-05
Sponsor: Seagen
Protocol Title: A randomized, double-blind, phase 3 study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for metastatic HER2+ breast cancer
Clinicaltrials.gov Number: NCT05132582